Home   >  Publication Citing Use of Biochempartner Products
  • Publication Citing Use of Biochempartner Products
Experimental Treatment of Mucinous Peritoneal Metastases Using Patient-Derived Xenograft Models

Publications Citing of Biochempartner's Cabazitaxel(CAS:183133-96-2)

Genetic and Virulence Characteristics of Linezolid and Pretomanid Dual Drug-Resistant Strains Induced from Mycobacterium tuberculosis in vitro

Publications Citing of Biochempartner's PA-824(CAS:187235-37-6)

Oral delivery of anti-TNF antibody shielded by natural polyphenol-mediated supramolecular assembly for inflammatory bowel disease therapy

Publications Citing of Biochempartner's Infliximab(CAS:170277-31-3)

Characterization of the ERG-regulated Kinome in Prostate Cancer Identifies TNIK as a Potential Therapeutic Target12

Publications Citing of Biochempartner's SU-6668(CAS:252916-29-3)

A bifunctional molecule-based strategy for the development of theranostic antibody-drug conjugate

Publications Citing of Biochempartner's Trastuzumab emtansine(CAS:1018448-65-1)

Direct derivation of human alveolospheres for SARS-CoV-2 infection modeling and drug screening

Publications Citing of Biochempartner's Wnt-C59(CAS:1243243-89-1)

Targeting of the AXL receptor tyrosine kinase by small molecule inhibitor leads to AXL cell surface accumulation by impairing the ubiquitin-dependent receptor degradation

Publications Citing of Biochempartner's BMS 777607(CAS:1196681-44-3)

Superhydrophobic hemostatic nanofiber composites for fast clotting and minimal adhesion

Publications Citing of Biochempartner's Argatroban(CAS:74863-84-6)

Stromal Modulation and Treatment of Metastatic Pancreatic Cancer with Local Intraperitoneal Triple miRNA/siRNA Nanotherapy

Publications Citing of Biochempartner's Plerixafor(CAS:110078-46-1)

Blockade of Arginine Vasopressin receptors prevents blood-brain barrier breakdown in Experimental Autoimmune Encephalomyelitis

Publications Citing of Biochempartner's Conivaptan(CAS:210101-16-9)

mTOR Promotes Tissue Factor Expression and Activity in EGFR-Mutant Cancer

Publications Citing of Biochempartner's AZD8055(CAS:1009298-09-2);WYE-125132(CAS:1144068-46-1);Rapamycin(CAS:53123-88-9)

The MYC Paralog-PARP1 Axis as a Potential Therapeutic Target in MYC Paralog-Activated Small Cell Lung Cancer

Publications Citing of Biochempartner's Talazoparib(CAS:1207456-01-6)

Dexmedetomidine protects against endothelial injury in septic rats induced by cecal ligation and puncture by decreasing angiopoietin 2 and increasing vascular endothelial cadherin levels

Publications Citing of Biochempartner's Chloral hydrate(CAS:302-17-0)

RGD-Conjugated Resveratrol HSA Nanoparticles as a Novel Delivery System in Ovarian Cancer Therapy

Publications Citing of Biochempartner's GRGDNP(CAS:114681-65-1)

Primary Clofazimine and Bedaquiline Resistance among Isolates from Patients with Multidrug-Resistant Tuberculosis

Publications Citing of Biochempartner's Clofazimine(CAS:2030-63-9);Bedaquiline(CAS:843663-66-1)

mTOR complex-2 stimulates acetyl-CoA and de novo lipogenesis through ATP citrate lyase in HER2/PIK3CA-hyperactive breast cancer

Publications Citing of Biochempartner's AZD8055(CAS:1009298-09-2);WYE-125132(CAS:1144068-46-1);Lapatinib(CAS:231277-92-2);PI-103(CAS:371935-74-9);Rapamycin(CAS:53123-88-9);GDC-0941(CAS:957054-30-7)

A novel cell culture system modeling the SARS-CoV-2 life cycle

Publications Citing of Biochempartner's Lopinavir(CAS:192725-17-0);Ribavirin(CAS:36791-04-5)

Conjugate Polyplexes with Anti-Invasive Properties and Improved siRNA Delivery In Vivo

Publications Citing of Biochempartner's Plerixafor(CAS:110078-46-1)

The TSC1‐mTOR‐PLK axis regulates the homeostatic switch from Schwann cell proliferation to myelination in a stage‐specific manner

Publications Citing of Biochempartner's BI 2536(CAS:755038-02-9)

Novel-smoothened inhibitors for therapeutic targeting of naïve and drug-resistant hedgehog pathway-driven cancers

Publications Citing of Biochempartner's Vismodegib(CAS:879085-55-9)

123下一页共 43 条记录 1 / 3 页 
0086-15971444841